Effect of oral hesperidin supplementation on glycemic and lipidemicin risk factors and inflammatory and oxidant markers in type 2 diabetes
Phase 2
Completed
- Conditions
- Diabetes.Diabetes mellitusE10, E11,
- Registration Number
- IRCT2015081810181N6
- Lead Sponsor
- Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
inclusion criteria:
having type 2 diabetes for at least 3 years, oral hypoglycemic medications consumption and having informed written consent
exclusion criteria:
any change in type or dose of drug during the last 3 months, BMI ranges above 30, having history of other endocrine disorders, heart, hepatic and kidney diseases,using steroid drugs or hormones, having vitamin or mineral supplementation during previous 3 month
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method